Actavis Reports Record Profits And EBITDA Margins In Third Quarter Published: Nov 15, 2005 Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announces its results for the third quarter ended 30 September 2005. Related links Prime Zone This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news